Randi Nygaard

1.3k total citations
26 papers, 885 citations indexed

About

Randi Nygaard is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Randi Nygaard has authored 26 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Hematology. Recurrent topics in Randi Nygaard's work include Acute Lymphoblastic Leukemia research (15 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Acute Myeloid Leukemia Research (6 papers). Randi Nygaard is often cited by papers focused on Acute Lymphoblastic Leukemia research (15 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Acute Myeloid Leukemia Research (6 papers). Randi Nygaard collaborates with scholars based in Norway, Denmark and Finland. Randi Nygaard's co-authors include Peter Johan Moe, Erik Forestier, Kjeld Schmiegelow, Niels Clausen, Guđmundur Jónmundsson, Ann-Inger Sommer, Jo‐Ann C. Leong, Børre Robertsen, Anders Glomstein and Anne Mäkipernaa and has published in prestigious journals such as Blood, Scientific Reports and British Journal of Haematology.

In The Last Decade

Randi Nygaard

25 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randi Nygaard Norway 15 474 342 179 164 142 26 885
Janez Jazbec Slovenia 19 443 0.9× 257 0.8× 151 0.8× 267 1.6× 221 1.6× 71 1.1k
Marlène Pasquet France 20 348 0.7× 162 0.5× 285 1.6× 219 1.3× 184 1.3× 59 1.1k
L Zanesco Italy 17 333 0.7× 141 0.4× 397 2.2× 151 0.9× 206 1.5× 53 914
Jack Bartram United Kingdom 18 291 0.6× 170 0.5× 339 1.9× 185 1.1× 115 0.8× 50 883
Sophia Polychronopoulou Greece 18 303 0.6× 268 0.8× 148 0.8× 149 0.9× 233 1.6× 76 891
Lesley J. Ashton Australia 21 284 0.6× 293 0.9× 98 0.5× 255 1.6× 108 0.8× 38 1.2k
Ah Moy Tan Singapore 14 207 0.4× 158 0.5× 181 1.0× 103 0.6× 78 0.5× 50 542
Concetta Micalizzi Italy 22 347 0.7× 155 0.5× 593 3.3× 331 2.0× 214 1.5× 81 1.2k
Shih‐Hsiang Chen Taiwan 17 166 0.4× 200 0.6× 296 1.7× 253 1.5× 88 0.6× 106 897

Countries citing papers authored by Randi Nygaard

Since Specialization
Citations

This map shows the geographic impact of Randi Nygaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randi Nygaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randi Nygaard more than expected).

Fields of papers citing papers by Randi Nygaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randi Nygaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randi Nygaard. The network helps show where Randi Nygaard may publish in the future.

Co-authorship network of co-authors of Randi Nygaard

This figure shows the co-authorship network connecting the top 25 collaborators of Randi Nygaard. A scholar is included among the top collaborators of Randi Nygaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randi Nygaard. Randi Nygaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Svanevik, Marius, Elling Ulvestad, Tore Stenstad, et al.. (2022). Investigating the human jejunal microbiota. Scientific Reports. 12(1). 1682–1682. 27 indexed citations
3.
Nygaard, Randi, et al.. (2020). Characterization of abscesses from liver, pancreas and kidney using deep sequencing of the 16S rRNA gene. Diagnostic Microbiology and Infectious Disease. 99(3). 115277–115277. 7 indexed citations
4.
Nygaard, Randi, et al.. (2019). Eikenella exigua sp. nov., isolated from brain abscess and blood. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 70(3). 1478–1488. 6 indexed citations
5.
Nygaard, Randi, et al.. (2019). Bacteria and fungi in acute cholecystitis. A prospective study comparing next generation sequencing to culture. Journal of Infection. 80(1). 16–23. 28 indexed citations
6.
Nygaard, Randi & Sanna‐Maria Kivivuori. (2011). Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. Anti-Cancer Drugs. 23(3). 342–346. 8 indexed citations
7.
Schmiegelow, Kjeld, Mette Klarskov Andersen, Mikael Behrendtz, et al.. (2009). Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood. 113(24). 6077–6084. 95 indexed citations
9.
Frost, Britt‐Marie, Peter Nygren, Göran Gustafsson, et al.. (2003). Increased in vitro cellular drug resistance is related to poor outcome in high‐risk childhood acute lymphoblastic leukaemia. British Journal of Haematology. 122(3). 376–385. 26 indexed citations
10.
Stensvåg, Klara, et al.. (2003). The spotted wolffish (Anarhichas minor Olafsen) complement component C3: isolation, characterisation and tissue distribution. Fish & Shellfish Immunology. 15(1). 13–27. 24 indexed citations
11.
Seidel, H., Anders Andersen, Jan Terje Kvaløy, et al.. (2000). Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables. Leukemia Research. 24(3). 193–199. 29 indexed citations
12.
Nygaard, Randi, et al.. (2000). Induction of Mx protein by interferon and double-stranded RNA in salmonid cells. Fish & Shellfish Immunology. 10(5). 435–450. 114 indexed citations
13.
Gustafsson, Göran, Kjeld Schmiegelow, Erik Forestier, et al.. (2000). Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia. 14(12). 2267–2275. 234 indexed citations
14.
Seidel, H., Randi Nygaard, Peter Johan Moe, et al.. (1997). On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia. Leukemia Research. 21(5). 429–434. 18 indexed citations
15.
Seidel, H., et al.. (1994). Evaluation of Serious Adverse Events in Patients Treated with Protocols Including Methotrexate Infusions. Pediatric Hematology and Oncology. 11(2). 165–172. 24 indexed citations
16.
Nygaard, Randi, Niels Clausen, Martti A. Siimes, et al.. (1991). Reproduction following treatment for childhood leukemia: A population‐based prospective cohort study of fertility and offspring. Medical and Pediatric Oncology. 19(6). 459–466. 66 indexed citations
17.
Nygaard, Randi, Stanislaw Garwicz, Tor Haldorsen, et al.. (1991). Second Malignant Neoplasms in Patients Treated for Childhood Leukemia: A Population‐based Cohort Study from the Nordic Countries. Acta Paediatrica. 80(12). 1220–1228. 71 indexed citations
18.
Nygaard, Randi, Peter Johan Moe, H Brincker, et al.. (1989). Late relapses after treatment for acute lymphoblastic leukemia in childhood: A population‐based study from the nordic countries. Medical and Pediatric Oncology. 17(1). 45–47. 22 indexed citations
19.
Nygaard, Randi, Kristian S. Bjerve, Svein Kolmannskog, Peter Johan Moe, & Finn Wesenberg. (1988). Thyroid Function in Children after Cytostatic Treatment for Acute Leukemia. Pediatric Hematology and Oncology. 5(1). 35–38. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026